Related references
Note: Only part of the references are listed.Immunoglobulin A: magic bullet or Trojan horse?
Marieke H. Heineke et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2017)
The truth on IgD in the ploy of immune surveillance and inflammation
Donato Rigante
IMMUNOLOGIC RESEARCH (2016)
Treatment with anti-cytokine monoclonal antibodies can potentiate the target cytokine rather than neutralize its activity
C. D. Rudulier et al.
ALLERGY (2016)
Immunoglobulin E, what is it good for?
Brian T. Kelly et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2016)
Human B-cell isotype switching origins of IgE
Timothy J. Looney et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
Eugene R. Bleecker et al.
LANCET (2016)
Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial
Sally Wenzel et al.
LANCET (2016)
Benralizumab, an anti-interleukin-5 receptor a monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial
J. Mark FitzGerald et al.
LANCET (2016)
EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders
O. Boyman et al.
ALLERGY (2015)
Guidelines for Severe Uncontrolled Asthma
Carolina Cisneros Serrano et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2015)
The discovery and development of omalizumab for the treatment of asthma
Amelia Licari et al.
EXPERT OPINION ON DRUG DISCOVERY (2015)
Population-based data on asthma and allergic disease call for advanced epidemiologic methods
Catarina Almqvist et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Allergic sensitization is age-dependently associated with rhinitis, but less so with asthma
Katja Warm et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations
Stephen J. Teach et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Asthma phenotypes and the use of biologic medications in asthma and allergic disease: The next steps toward personalized care
Merritt L. Fajt et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Different IgE recognition of mite allergen components in asthmatic and nonasthmatic children
Yvonne Resch et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Guidelines for Severe Uncontrolled Asthma
Carolina Cisneros Serrano et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2015)
Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials
Mario Castro et al.
LANCET RESPIRATORY MEDICINE (2015)
The IgE response to Ascaris molecular components is associated with clinical indicators of asthma severity
Emiro Buendia et al.
WORLD ALLERGY ORGANIZATION JOURNAL (2015)
Omalizumab therapy is associated with reduced circulating basophil populations in asthmatic children
D. A. Hill et al.
ALLERGY (2014)
Omalizumab for Severe Asthma: Efficacy Beyond the Atopic Patient?
Christian Domingo
DRUGS (2014)
Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
Elisabeth H. Bel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
Hector G. Ortega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Against all odds: anti-IgE for intrinsic asthma?
Marek Lommatzsch et al.
THORAX (2014)
Omalizumab in Asthma: An Update on Recent Developments
Marc Humbert et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2014)
The production and regulation of IgE by the immune system
Lawren C. Wu et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Longitudinal increase in total IgE levels in patients with adult asthma: an association with poor asthma control
Akihiko Tanaka et al.
RESPIRATORY RESEARCH (2014)
The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three: A global synthesis
J. Mallol et al.
ALLERGOLOGIA ET IMMUNOPATHOLOGIA (2013)
An investigation into IgE-facilitated allergen recognition and presentation by human dendritic cells
Inas K. Sharquie et al.
BMC IMMUNOLOGY (2013)
The Cost of Persistent Asthma in Europe: An International Population-Based Study in Adults
Simone Accordini et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2013)
Omalizumab Attenuates Airway Inflammation and Interleukin-5 Production by Mononuclear Cells in Patients with Severe Allergic Asthma
Yotaro Takaku et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2013)
Mild Asthma
Elisabeth H. Bel
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The Role of IgE-Receptors in IgE-Dependent Airway Smooth Muscle Cell Remodelling
Michael Roth et al.
PLOS ONE (2013)
IgE induces proliferation in human airway smooth muscle cells: role of MAPK and STAT3 pathways
Naresh Singh Redhu et al.
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (2013)
International consensus on (ICON) pediatric asthma
N. G. Papadopoulos et al.
ALLERGY (2012)
Mast cells and inflammation
Theoharis C. Theoharides et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)
Asthma in Children and Adolescents: A Comprehensive Approach to Diagnosis and Management
Christopher Chang
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2012)
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
Ian D. Pavord et al.
LANCET (2012)
IgE and mast cells in allergic disease
Stephen J. Galli et al.
NATURE MEDICINE (2012)
Asthma phenotypes: the evolution from clinical to molecular approaches
Sally E. Wenzel
NATURE MEDICINE (2012)
The role of mast cells in allergic inflammation
Kawa Amin
RESPIRATORY MEDICINE (2012)
EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy
Moises A Calderon et al.
Clinical and Translational Allergy (2012)
The function and regulation of immunoglobulin D
Kang Chen et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome
Jan Lotvall et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children
William W. Busse et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The effects of omalizumab on IgE-induced cytokine synthesis by asthmatic airway smooth muscle cells
Michael Roth et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2010)
Narrative Review: The Role of Th2 Immune Pathway Modulation in the Treatment of Severe Asthma and Its Phenotypes
Stewart J. Levine et al.
ANNALS OF INTERNAL MEDICINE (2010)
The other side of immunoglobulin G: suppressor of inflammation
S. Aschermann et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Omalizumab in children with inadequately controlled severe allergic (IgE-mediated) asthma
M. Kulus et al.
CURRENT MEDICAL RESEARCH AND OPINION (2010)
Predictors of remitting, periodic, and persistent childhood asthma
Ronina A. Covar et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Counterregulation between the FcεRI Pathway and Antiviral Responses in Human Plasmacytoid Dendritic Cells
Michelle A. Gill et al.
JOURNAL OF IMMUNOLOGY (2010)
Effect of omalizumab on peripheral blood eosinophilia in allergic asthma
M. Massanari et al.
RESPIRATORY MEDICINE (2010)
How are TH2-type immune responses initiated and amplified?
William E. Paul et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Relationship between omalizumab pharmacokinetics, IgE pharmacodynamics and symptoms in patients with severe persistent allergic (IgE-mediated) asthma
Philip J. Lowe et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Worldwide time trends for symptoms of rhinitis and conjunctivitis: Phase III of the International Study of Asthma and Allergies in Childhood
Bengt Bjorksten et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2008)
The mast cell and allergic diseases: role in pathogenesis and implications for therapy
J. M. Brown et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2008)
Association between IgE levels and asthma severity among African American, Mexican, and Puerto Rican patients with asthma
Mariam Naqvi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
A Recombinant Humanized Anti-IgE Monoclonal Antibody (Omalizumab) in the Therapy of Moderate-to-Severe Allergic Asthma
D'Amato Gennaro et al.
RECENT PATENTS ON INFLAMMATION & ALLERGY DRUG DISCOVERY (2007)
Secondary prevention of asthma by the use of inhaled fluticasone propionate in wheezy infants (IFWIN): double-blind, randomised, controlled study
Clare S. Murray et al.
LANCET (2006)
Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood:: ISAAC Phases One and Three repeat multicountry cross-sectional surveys
M. Innes Asher et al.
LANCET (2006)
Asthma severity and atopy: how clear is the relationship?
WD Carroll et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2006)
Natural serum IgM maintains immunological homeostasis and prevents autoimmunity
JJ Manson et al.
SPRINGER SEMINARS IN IMMUNOPATHOLOGY (2005)
The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma
J Bousquet et al.
ALLERGY (2005)
The allergy epidemic extends beyond the past few decades
E Isolauri et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2004)
The prevention of early asthma in kids study: design, rationale and methods for the childhood asthma research and education network
TW Guilbert et al.
CONTROLLED CLINICAL TRIALS (2004)
Relationships of allergic sensitization, total immunoglobulin E and blood eosinophils to asthma severity in children of the EGEA Study
V Siroux et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2003)
Mast cell-derived exosomes induce phenotypic and functional maturation of dendritic cells and elicit specific immune responses in vivo
D Skokos et al.
JOURNAL OF IMMUNOLOGY (2003)
Allergen-specific immunoglobulin E antibodies in wheezing infants:: The risk for asthma in later childhood -: art. no. e255
A Kotaniemi-Syrjänen et al.
PEDIATRICS (2003)
Omalizumab improves asthma-related quality of life in patients with severe allergic asthma
A Finn et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalizations in patients with allergic asthma
J Corren et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma
R Buhl et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics
M Solèr et al.
EUROPEAN RESPIRATORY JOURNAL (2001)
The prevalence of environmental exposure to perceived asthma triggers in children with mild-to-moderate asthma: Data from the Childhood Asthma Management Program (CAMP)
ST Weiss et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
Regulation of the inflammatory response in asthma by mast cell products
PH Hart
IMMUNOLOGY AND CELL BIOLOGY (2001)
Conventional, naive CD4+ T cells provide an initial source of IL-4 during Th2 differentiation
N Noben-Trauth et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
